Cargando…
Production costs and potential prices for biosimilars of human insulin and insulin analogues
INTRODUCTION: High prices for insulin pose a barrier to treatment for people living with diabetes, with an estimated 50% of 100 million patients needing insulin lacking reliable access. As insulin analogues replace regular human insulin (RHI) globally, their relative prices will become increasingly...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157569/ https://www.ncbi.nlm.nih.gov/pubmed/30271626 http://dx.doi.org/10.1136/bmjgh-2018-000850 |